TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Pharmaceuticals - Everolimus and terminated agreement products

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS National Pharmaceuticals - Everolimus and terminated agreement products". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46Bids / Report
1.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published28 Sept 2021, 12:36 BST
Last source update28 Sept 2021, 12:36 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-02a471
What is being bought
Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022
What changed
From the official release history
  1. tender value changed
    28 Sept 2021, 12:36 BST
  2. Status changed to complete
    28 Sept 2021, 12:36 BST
  3. Official notice release published
    28 Sept 2021, 12:36 BST
  4. Submission deadline changed to published date
    28 Sept 2021, 12:36 BST
  5. Published value updated to £18,720,512
    9 Apr 2021, 15:35 BST
  6. Status changed to active
    9 Apr 2021, 15:35 BST
  7. Official notice release published
    9 Apr 2021, 15:35 BST
  8. Submission deadline changed to 26 Apr 2021, 13:00 BST
    9 Apr 2021, 15:35 BST
  9. Buyer information updated
    9 Apr 2021, 15:35 BST
Lots and requirements (3)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - CM/PHG/21/5632/00 Everolimus
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632/00Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - CM/PHG/21/5632/01 Oral (plus non parenteral) products
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Lot 3 - CM/PHG/21/5632/02 Hospital Only products
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    28 Sept 2021, 12:36 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Award active
    Not published · Not published
  36. Award active
    Not published · Not published
  37. Award active
    Not published · Not published
  38. Award active
    Not published · Not published
  39. Award active
    Not published · Not published
  40. Award active
    Not published · Not published
  41. Award active
    Not published · Not published
  42. Award active
    Not published · Not published
  43. Award active
    Not published · Not published
  44. Award active
    Not published · Not published
  45. Award active
    Not published · Not published
  46. Award active
    Not published · Not published
  47. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  48. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  49. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  50. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  51. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  52. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  53. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  54. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  55. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  56. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  57. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  58. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  59. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  60. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  61. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  62. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  63. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  64. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  65. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  66. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  67. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  68. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  69. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  70. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  71. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  72. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  73. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  74. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  75. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  76. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  77. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  78. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  79. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  80. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  81. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  82. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  83. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  84. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  85. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  86. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  87. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  88. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  89. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  90. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
  91. Contract active
    Signed 8 Jun 2021, 00:00 BST · £1
Commercial outcome and competition
Awards
Selective Supplies Ltd.
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Bristol Laboratories Limited
Not published · Not published · active
Drugsrus Ltd
Not published · Not published · active
Bowmed Ibisqus Limited
Not published · Not published · active
Martindale Pharma
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Crescent Pharma Ltd
Not published · Not published · active
Fresenius Kabi Limited
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Mylan
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Medreich PLC
Not published · Not published · active
Torrent Pharma UK Ltd
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Fresenius Kabi Limited
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Mylan
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Medreich PLC
Not published · Not published · active
Torrent Pharma UK Ltd
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Bristol Laboratories Limited
Not published · Not published · active
Drugsrus Ltd
Not published · Not published · active
Bowmed Ibisqus Limited
Not published · Not published · active
Martindale Pharma
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Crescent Pharma Ltd
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Bristol Laboratories Limited
Not published · Not published · active
Drugsrus Ltd
Not published · Not published · active
Bowmed Ibisqus Limited
Not published · Not published · active
Martindale Pharma
Not published · Not published · active
Milpharm Ltd/aurobinbdo
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Crescent Pharma Ltd
Not published · Not published · active
Fresenius Kabi Limited
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Mylan
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Medreich PLC
Not published · Not published · active
Torrent Pharma UK Ltd
Not published · Not published · active
Contracts
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
£1 · signed 8 Jun 2021, 00:00 BST · active
Bid statistics
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
smeBids: 2 (lot 1)
bids: 24 (lot 2)
bids: 24 (lot 2)
bids: 24 (lot 2)
bids: 24 (lot 2)
bids: 24 (lot 2)
Buyer and organisations in this procedure

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authority GB-FTS-2505
View buyer profile
  • The NHS Commissioning Board (operating under the name of NHS England)
    buyer
    centralPurchasingBody

    2nd Floor, Rutland House, Runcorn, UK, WA7 2ES
  • Accord-UK Ltd
    supplier

    Whiddon Valley, Barnstaple, UK, EX32 8NS
  • Bowmed Ibisqus Limited
    supplier

    2 Jordan Street, Knott Mill, Manchester, UK, M15 4PY
  • Bristol Laboratories Limited
    supplier

    Bristol House, Unit 3 Canalside, Northbridge Road, Berkhamsted, UK, HP4 1EG
  • Crescent Pharma Ltd
    supplier

    Key House, Sarum Hill, Basingstoke, UK, RG21 8SR
  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    6 Riverview Road, Beverley, UK, HU17 0LD
  • Drugsrus Ltd
    supplier

    36a Joel Street, Northwood, UK, HA6 1NZ
  • Fresenius Kabi Limited
    supplier

    Cestrian Court, Eastgate Way, Manor Park, Runcorn, UK, WA7 1NT
  • Martindale Pharma
    supplier

    Bampton Road, Harold Hill, Romford, UK, RM3 8UG
  • Medreich PLC
    supplier

    Ibex House, Baker Street, Weybridge, UK, KT13 8AH
  • Milpharm Ltd/aurobinbdo
    supplier

    Ares Block, Odyssey Business Park, West End Road, South Ruislip, UK, HA4 6QD
  • Mylan
    supplier

    20 Station Close, Potters Bar, UK, EN6 1TL
  • Ranbaxy UK
    supplier

    5th Floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UK, UB3 4AZ
  • Selective Supplies Ltd.
    supplier

    Roxburghe House, 273/287 Regent St., London, UK, W1B 2HA
  • Teva UK Limited
    supplier

    Ridings Point, Whistler Drive, Castleford, UK, WF10 5HX
  • The High Court
    reviewBody

  • Torrent Pharma UK Ltd
    supplier

    Third Floor, Nexus Building, 4 Gatwick Road, Crawley, UK, RH10 9BG
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published